back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-11-08 12:48 Tx date 2024-11-07 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
2,150,000 | |
| Filed 2024-11-08 12:28 Tx date 2024-11-07 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-1,000,000 vol $0.10 each |
7,050,000 | |
| Filed 2024-10-14 12:43 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Glass, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
100,000 | |
| Filed 2024-10-14 12:42 Tx date 2024-05-30 |
$QPT
Quest PharmaTech Inc. |
Glass, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-10-14 12:30 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
2,400,000 | |
| Filed 2024-10-14 12:24 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
1,150,000 | |
| Filed 2024-10-14 12:20 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$62,500
+1,250,000 vol $0.05 each |
8,050,000 | |
| Filed 2023-09-18 10:53 Tx date 2023-09-15 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,070
+15,290 vol $0.07 each |
2,200,000 | |
| Filed 2023-09-07 15:02 Tx date 2023-09-06 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$560.00
+8,000 vol $0.07 each |
2,184,710 | |
| Filed 2023-08-30 11:24 Tx date 2023-08-29 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+30,000 vol $0.07 each |
2,176,710 | |
| Filed 2023-08-28 13:25 Tx date 2023-08-25 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+20,000 vol $0.07 each |
2,146,710 | |
| Filed 2023-08-23 12:26 Tx date 2023-08-22 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+30,000 vol $0.07 each |
2,126,710 | |
| Filed 2023-07-24 17:32 Tx date 2023-07-24 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
2,150,000 | |
| Filed 2023-07-24 17:28 Tx date 2023-07-24 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-1,000,000 vol $0.10 each |
6,800,000 | |
| Filed 2023-07-17 16:00 Tx date 2023-07-13 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+200,000 vol $0.08 each |
500,000 | |
| Filed 2023-07-17 15:06 Tx date 2023-07-13 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+300,000 vol $0.08 each |
2,400,000 | |
| Filed 2023-07-17 15:01 Tx date 2023-07-13 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+750,000 vol $0.08 each |
7,800,000 | |
| Filed 2023-07-17 14:52 Tx date 2023-07-13 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+300,000 vol $0.08 each |
1,050,000 | |
| Filed 2023-06-12 17:03 Tx date 2023-06-09 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+250,000 vol $0.10 each |
2,100,000 | |
| Filed 2023-06-12 15:26 Tx date 2023-06-09 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+1,000,000 vol $0.10 each |
7,050,000 | |
| Filed 2022-07-25 14:59 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+300,000 vol $0.09 each |
1,850,000 | |
| Filed 2022-07-25 10:59 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+200,000 vol $0.09 each |
700,000 | |
| Filed 2022-07-25 10:52 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+300,000 vol $0.09 each |
750,000 | |
| Filed 2022-07-25 10:44 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+300,000 vol $0.09 each |
6,050,000 | |
| Filed 2022-07-22 10:59 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,000
+100,000 vol $0.09 each |
1,795,000 | |
| Filed 2022-07-21 18:54 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
300,000 | |
| Filed 2022-04-14 23:47 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,500
+45,000 vol $0.10 each |
1,695,000 | |
| Filed 2022-04-14 23:45 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,500
-45,000 vol $0.10 each |
1,650,000 | |
| Filed 2022-04-14 11:45 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,000
+400,000 vol $0.10 each |
2,096,710 | |
| Filed 2022-04-14 11:39 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-40,000
-400,000 vol $0.10 each |
5,750,000 | |
| Filed 2022-04-14 11:36 Tx date 2022-04-11 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+300,000 vol $0.10 each |
6,150,000 | |
| Filed 2022-04-14 11:12 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,500
+45,000 vol $0.10 each |
899,756 | |
| Filed 2022-04-14 10:59 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,500
-45,000 vol $0.10 each |
1,550,000 | |
| Filed 2021-07-13 15:10 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2021-07-07 18:07 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-09 18:54 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+150,000 vol $0.10 each |
450,000 | |
| Filed 2021-07-09 18:32 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+100,000 vol $0.10 each |
||
| Filed 2021-07-09 18:31 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2021-07-09 17:19 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+100,000 vol $0.10 each |
500,000 | |
| Filed 2021-07-07 18:12 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2021-07-07 18:07 Tx date 2021-07-05 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
375,000 | ||
| Filed 2021-06-02 13:22 Tx date 2021-06-02 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-15,000
-150,000 vol $0.10 each |
1,595,000 | |
| Filed 2021-06-02 13:20 Tx date 2021-06-02 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-110,000
-1,100,000 vol $0.10 each |
5,850,000 | |
| Filed 2021-06-02 13:16 Tx date 2021-06-02 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
1,695,000 | |
| Filed 2021-06-02 13:14 Tx date 2021-05-26 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,750
+250,000 vol $0.115 each |
1,945,000 | |
| Filed 2021-05-28 15:38 Tx date 2021-05-26 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,250
+150,000 vol $0.115 each |
1,745,000 | |
| Filed 2021-05-28 15:34 Tx date 2021-05-26 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$126,500
+1,100,000 vol $0.115 each |
6,950,000 | |
| Filed 2021-01-06 12:01 Tx date 2021-01-05 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,000
+500,000 vol $0.23 each |
1,595,000 | |
| Filed 2021-01-06 11:56 Tx date 2021-01-05 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,000
+1,000,000 vol $0.23 each |
5,850,000 | |
| Filed 2021-01-04 15:49 Tx date 2021-01-03 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-50,000
-500,000 vol $0.10 each |
4,850,000 | |
| Filed 2021-01-04 15:43 Tx date 2021-01-03 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
1,095,000 | |
| Filed 2021-01-04 15:37 Tx date 2020-12-31 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+250,000 vol $0.10 each |
751,334 | |
| Filed 2021-01-04 15:13 Tx date 2020-12-31 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+250,000 vol $0.10 each |
1,695,000 | |
| Filed 2020-03-10 13:08 Tx date 2020-02-26 |
$QPT
Quest PharmaTech Inc. |
Zhao, Jessica
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-10 13:07 Tx date 2020-02-26 |
$QPT
Quest PharmaTech Inc. |
Zhao, Jessica
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-01-28 13:37 Tx date 2020-01-26 |
$QPT
Quest PharmaTech Inc. |
Van Damme, Paul Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,000
-100,000 vol $0.10 each |
450,000 | |
| Filed 2020-01-27 15:53 Tx date 2020-01-26 |
$QPT
Quest PharmaTech Inc. |
Meikle, Lorne
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-100,000 vol |
1,100,000 | |
| Filed 2020-01-27 15:50 Tx date 2020-01-22 |
$QPT
Quest PharmaTech Inc. |
Meikle, Lorne
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,000
+50,000 vol $0.10 each |
52,000 | |
| Filed 2020-01-27 15:48 Tx date 2020-01-22 |
$QPT
Quest PharmaTech Inc. |
Meikle, Lorne
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,000
-50,000 vol $0.10 each |
1,200,000 | |
| Filed 2020-01-16 19:02 Tx date 2020-01-15 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
854,756 | |
| Filed 2020-01-16 18:48 Tx date 2020-01-15 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-150,000 vol $0.10 each |
1,345,000 | |
| Filed 2020-01-15 17:30 Tx date 2020-01-15 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
501,334 | |
| Filed 2020-01-15 17:08 Tx date 2020-01-15 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-150,000 vol $0.10 each |
1,445,000 | |
| Filed 2019-05-10 14:22 Tx date 2019-01-31 |
$QPT
Quest PharmaTech Inc. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,650
+10,000 vol $0.165 each |
10,000 | |
| Filed 2019-05-10 14:17 Tx date 2017-11-02 |
$QPT
Quest PharmaTech Inc. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Meikle, Lorne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
1,250,000 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+500,000 vol $0.18 each |
5,350,000 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
1,495,000 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
300,000 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
400,000 | |
| Filed 2019-01-31 Tx date 2019-01-28 |
$QPT
Quest PharmaTech Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-31 Tx date 2019-01-28 |
$QPT
Quest PharmaTech Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+150,000 vol $0.18 each |
150,000 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
250,000 | |
| Filed 2019-01-30 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
1,595,000 | |
| Filed 2018-10-12 Tx date 2018-10-09 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$30,000
+300,000 vol $0.10 each |
1,696,710 | |
| Filed 2018-10-12 Tx date 2018-10-09 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,000
-300,000 vol $0.10 each |
4,850,000 | |
| Filed 2018-06-14 Tx date 2018-05-18 |
$QPT
Quest PharmaTech Inc. |
Bu, Haihua
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-14 Tx date 2018-05-18 |
$QPT
Quest PharmaTech Inc. |
Bu, Haihua
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,395,000 | |
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Meikle, Lorne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,150,000 | |
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2018-01-04 Tx date 2017-11-02 |
$QPT
Quest PharmaTech Inc. |
Meekison, William John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
5,150,000 | |
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
300,000 | |
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
200,000 | |
| Filed 2018-01-03 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
1,495,000 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
54 - Exercise of warrants
|
-150,000 vol |
1,245,000 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$15,000
+150,000 vol $0.10 each |
704,756 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Shi, Yuenian Eric
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-1,666,667 vol |
0 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Shi, Yuenian Eric
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$166,666
+1,666,667 vol $0.10 each |
3,333,334 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
54 - Exercise of warrants
|
-1,000,000 vol |
4,650,000 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-100,000
-1,000,000 vol $0.10 each |
1,396,710 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$100,000
+1,000,000 vol $0.10 each |
2,396,710 | |
| Filed 2017-07-24 Tx date 2017-07-19 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
150,000 | |
| Filed 2017-07-24 Tx date 2017-07-13 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-24 Tx date 2017-07-13 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-05 Tx date 2017-06-30 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,625
+112,500 vol $0.13 each |
861,762 | |
| Filed 2017-02-22 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
1,395,000 | |
| Filed 2017-02-22 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Shi, Yuenian Eric
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
650,000 | |
| Filed 2017-02-22 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Meikle, Lorne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
1,000,000 | |
| Filed 2017-02-22 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+350,000 vol $0.15 each |
5,650,000 | |
| Filed 2017-02-22 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
150,000 | |
| Filed 2017-02-20 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Woo, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
1,345,000 | |
| Filed 2017-02-17 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
McConnan, Ian Edward Walter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
1,150,000 | |
| Filed 2015-12-03 Tx date 2015-11-27 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-03 Tx date 2015-11-27 |
$QPT
Quest PharmaTech Inc. |
Lu, Shawn Shuguang
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-02 Tx date 2015-11-27 |
$QPT
Quest PharmaTech Inc. |
Shi, Yuenian Eric
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,666,667 | ||
| Filed 2015-12-02 Tx date 2015-11-27 |
$QPT
Quest PharmaTech Inc. |
Shi, Yuenian Eric
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,666,667 | ||
| Filed 2015-12-02 Tx date 2014-11-06 |
$QPT
Quest PharmaTech Inc. |
Huang, Bin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2015-12-02 Tx date 2014-11-06 |
$QPT
Quest PharmaTech Inc. |
Huang, Bin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-02 Tx date 2015-11-27 |
$QPT
Quest PharmaTech Inc. |
Shi, Yuenian Eric
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2015-11-06 Tx date 2015-11-05 |
$QPT
Quest PharmaTech Inc. |
Hepalink USA Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000,000 | ||
| Filed 2015-08-12 Tx date 2015-08-10 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
+150,000 vol |
1,245,000 | |
| Filed 2015-08-12 Tx date 2015-08-10 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,000
+150,000 vol $0.06 each |
749,262 | |
| Filed 2015-08-12 Tx date 2015-08-10 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
+1,000,000 vol |
5,300,000 | |
| Filed 2015-08-12 Tx date 2015-08-10 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+1,000,000 vol $0.06 each |
1,000,000 | |
| Filed 2015-08-12 Tx date 2004-06-17 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-27 Tx date 2015-07-24 |
$QPT
Quest PharmaTech Inc. |
Park, Mr. Gi-Ho
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-9,166,667 vol |
0 |